Sellas Life Sciences Group Inc (SLS.OQ)
SLS.OQ on NASDAQ Stock Exchange Capital Market
1.46USD
18 Jan 2019
1.46USD
18 Jan 2019
Change (% chg)
$-0.07 (-4.58%)
$-0.07 (-4.58%)
Prev Close
$1.53
$1.53
Open
$1.53
$1.53
Day's High
$1.54
$1.54
Day's Low
$1.46
$1.46
Volume
45,622
45,622
Avg. Vol
229,261
229,261
52-wk High
$11.08
$11.08
52-wk Low
$0.80
$0.80
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Angelos Stergiou |
2017 | President, Chief Executive Officer, Director | |
Nicholas Sarlis |
2018 | Chief Medical Officer, Executive Vice President | |
John Burns |
2018 | Principal Accounting Officer, Vice President - Finance, Controller | |
David Scheinberg |
2017 | Director | |
Stephen Ghighlieri |
56 | 2017 | Independent Director |